- Home
- BCRX vs DNN Comparison
BCRX vs DNN Comparison
Compare BCRX & DNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- DNN
- Stock Information
- Founded
- BCRX 1986
- DNN 1954
- Country
- BCRX United States
- DNN Canada
- Employees
- BCRX N/A
- DNN N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- DNN Other Metals and Minerals
- Sector
- BCRX Health Care
- DNN Basic Materials
- Exchange
- BCRX Nasdaq
- DNN Nasdaq
- Market Cap
- BCRX 1.8B
- DNN 1.8B
- IPO Year
- BCRX 1994
- DNN 1997
- Fundamental
- Price
- BCRX $7.28
- DNN $2.87
- Analyst Decision
- BCRX Strong Buy
- DNN Strong Buy
- Analyst Count
- BCRX 10
- DNN 1
- Target Price
- BCRX $16.70
- DNN $2.75
- AVG Volume (30 Days)
- BCRX 3.1M
- DNN 102.1M
- Earning Date
- BCRX 11-03-2025
- DNN 11-06-2025
- Dividend Yield
- BCRX N/A
- DNN N/A
- EPS Growth
- BCRX N/A
- DNN N/A
- EPS
- BCRX N/A
- DNN N/A
- Revenue
- BCRX $557,506,000.00
- DNN $3,311,190.00
- Revenue This Year
- BCRX $41.40
- DNN $197.76
- Revenue Next Year
- BCRX $5.33
- DNN $54.87
- P/E Ratio
- BCRX N/A
- DNN N/A
- Revenue Growth
- BCRX 45.85
- DNN 12.14
- 52 Week Low
- BCRX $6.02
- DNN $1.08
- 52 Week High
- BCRX $11.31
- DNN $2.99
- Technical
- Relative Strength Index (RSI)
- BCRX 38.42
- DNN 70.54
- Support Level
- BCRX $7.24
- DNN $2.70
- Resistance Level
- BCRX $7.47
- DNN $2.99
- Average True Range (ATR)
- BCRX 0.20
- DNN 0.16
- MACD
- BCRX -0.02
- DNN -0.01
- Stochastic Oscillator
- BCRX 34.85
- DNN 72.42
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About DNN Denison Mines Corp (Canada)
Denison Mines Corp is a uranium exploration and development company focused on the Athabasca Basin region of northern Saskatchewan, Canada. The company holds a noteworthy 95% interest in its flagship Wheeler River Uranium Project, the undeveloped uranium project located in the infrastructure-rich eastern part of the Athabasca Basin. Additionally, it is involved in mine decommissioning and environmental services through its Closed Mines group, which manages the Elliot Lake reclamation projects and offers third-party post-closure mine care and maintenance services. The Company operates in two main segments: the Mining segment and the Corporate and Other segment. The majority of revenue is generated from the mining segment.